Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGDS | O60760 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.31 |
| ▸ | GLRA3 | O75311 | 1/20 | 0.31 |
| ▸ | GLRB | P48167 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.31 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.31 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL66901 | 0.80 | HPGDS (0.48) | HPGDSLTA4HBRD4ADORA2AADORA1 | |
| SCHEMBL100765 | 0.76 | HPGDS (0.46) | HPGDSLTA4HBRD4ADORA2AADORA1 | |
| SCHEMBL17701262 | 0.74 | HPGDS (0.40) | HPGDSLTA4HBRD4ADORA2AADORA1 | |
| SCHEMBL13114685 | 0.73 | HPGDS (0.47) | HPGDSLTA4HBRD4ADORA2AADORA1 | |
| SCHEMBL17701235 | 0.73 | HPGDS (0.36) | HPGDSLTA4H | |
| SCHEMBL3079973 | 0.71 | CYP2D6 (0.39) | HPGDSLTA4HBRD4ADORA2AADORA1 | |
| SCHEMBL13737200 | 0.70 | HPGDS (0.53) | HPGDSLTA4HBRD4ADORA2AGLRA3 | |
| SCHEMBL14211174 | 0.69 | HPGDS (0.43) | HPGDSLTA4HBRD4ADORA2AADORA1 | |
| SCHEMBL5507183 | 0.68 | PPARA (0.40) | HPGDSLTA4HBRD4ADORA2AADORA1 | |
| SCHEMBL31351956 | 0.67 | PIN1 (0.39) | HPGDSLTA4HBRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102464611-A | Substitutional biaryl base benzene sulfonamide compound and application | SINOCHEM CORP | 2012-05-23 | — | — | CN | claimed |
| CN-102459289-A | Copper complexes for optoelectronic applications | HARTMUT YERSIN | 2012-05-16 | — | — | CN | claimed |
| CN-101959884-A | 6-heterocyclic imidazo [1, 2-alpha ] pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof | SANOFI AVENTIS | 2011-01-26 | — | — | CN | claimed |
| CN-100497326-C | 1-piperazine-and 1-homopiperazine-carboxylate derivatives, preparation and therapeutic use thereof | SANOFI AVENTIS (FR) | 2009-06-10 | — | — | CN | claimed |
| CN-113214270-A | Compounds and derivatives thereof as MDM2-P53 inhibitors | 勃林格殷格翰国际有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-108148063-A | Compound dimethoxy-styryl-amino-benzimidazole base-triazine and its salt and preparation method and application | 华南理工大学 | 2018-06-12 | — | — | CN | disclosed |
| US-9812315-B2 | Treating solution for electronic parts, and process for producing electronic parts | FINE POLYMERS CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-20150279654-A1 | TREATING SOLUTION FOR ELECTRONIC PARTS, AND PROCESS FOR PRODUCING ELECTRONIC PARTS | FINE POLYMERS CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| CN-103732065-A | Benzofuran compounds for the treatment of hepatitis c virus infections | GLAXO GROUP LTD | 2014-04-16 | — | — | CN | disclosed |
| CN-101068825-B | Having a2A2-propynyl adenosine analogs with modified 5' -ribose groups for agonist activity | Univ Virginia Patent Found | 2013-05-08 | — | — | CN | disclosed |
| CN-101959884-B | 6-heterocyclic imidazo [1,2-a ] pyridine-2-carboxamide derivatives, preparation and therapeutic use thereof | SANOFI AVENTIS | 2013-02-27 | — | — | CN | disclosed |
| CN-101541764-B | Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods | BASF SE | 2012-10-10 | — | — | CN | disclosed |
| US-20080107608-A1 | 5-Substituted-2-Arylpyridines | GE PING | 2008-05-08 | — | — | US | disclosed |
| CN-101146889-A | Luminous compound containing lanthanide ion | FUJIFILM CORP (JP) | 2008-03-19 | — | — | CN | disclosed |
| US-20070190523-A1 | Method and compositions for identifying anti-hiv therapeutic compounds | GILEAD SCIENCES, INC. | 2007-08-16 | — | — | US | disclosed |
| CN-1708571-A | Process for incorporation of UV-luminescent compounds in polymeric materials | CIBA SC HOLDING AG (CH) | 2005-12-14 | — | — | CN | disclosed |
| US-6667306-B1 | Aminobenzothiazole and aminobenzoxazole derivatives; thrombosis | MILLENNIUM PHARMACEUTICALS, INC. | 2003-12-23 | — | — | US | disclosed |
| EP-1047699-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 2000-11-02 | — | — | EP | disclosed |
| WO-1999036425-A1 | PLATELET ADP RECEPTOR INHIBITORS | COR THERAPEUTICS, INC. (US) | 1999-07-22 | — | — | WO | disclosed |
| CN-1200117-A | Phenylacetic acids, processes for their preparation and agents containing them | BASF AG (DE) | 1998-11-25 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080107608-A1 | 5-Substituted-2-Arylpyridines | CRHR2, CRHR1, HTR2C | HPGDS 1530/4885LTA4H 3187/4885BRD4 1835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.